相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Iron Deficiency Anemia on Hemoglobin A1c Levels
Nitin Sinha et al.
ANNALS OF LABORATORY MEDICINE (2012)
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)
Yutaka Mori et al.
ADVANCES IN THERAPY (2011)
Adverse effect profile of trichlormethiazide: a retrospective observational study
Yasuo Takahashi et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study
Yayoi Nishida et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Hyperkalemia and Renal Function During Monotherapy and Dual Renin-Angiotensin Blockade in the Community Setting
Daniel Kurnik et al.
CLINICAL THERAPEUTICS (2011)
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus
Gianpaolo Reboldi et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US
Earl S. Ford et al.
JOURNAL OF DIABETES (2011)
Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records
Yayoi Nishida et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Renin-Angiotensin System Dual Blockade Using Angiotensin Receptor Plus Aliskiren Decreases Severe Proteinuria in Kidney Transplant Recipients
V. Lopez et al.
TRANSPLANTATION PROCEEDINGS (2010)
The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control
Akiko Yamana et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks - Candesartan Antihypertensive Survival Evaluation in Japan Trial
Toshio Ogihara et al.
HYPERTENSION (2008)
Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study
Jan W. Eriksson et al.
HYPERTENSION (2008)
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency
Tsukasa Nakamura et al.
HYPERTENSION RESEARCH (2008)
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease
T. Fujita et al.
KIDNEY INTERNATIONAL (2007)
Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records
Noboru Kitamura et al.
CARDIOVASCULAR DIABETOLOGY (2007)
2007 guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Incident diabetes in clinical trials of anti hypertensive drugs: a network meta-analysis
William J. Elliott et al.
LANCET (2007)
The valsartan antihypertensive long-term use evaluation (VALUE) trial - Outcomes in patients receiving monotherapy
Stevo Julius et al.
HYPERTENSION (2006)
A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period
RN Formica et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b
Trevor G. Marshall et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2006)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis
A Ersoy et al.
TRANSPLANTATION PROCEEDINGS (2005)
Valsartan-induced hematocrit changes in renal transplant patients
CA Flores et al.
TRANSPLANTATION PROCEEDINGS (2005)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
The effects of losartan and fosinopril diabetic patients in hypertensive type 2
H Kavgaci et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2002)
Angiotensin-II receptor antagonist losartan reduces micro albuminuria in hypertensive renal transplant recipients
A Ersoy et al.
CLINICAL TRANSPLANTATION (2002)
分享论文
